Search results

Repair and Review in Nuclear Medicine Processing and Distribution Facility 20/07/2018

The Australian Nuclear Science and Technology Organisation (ANSTO) is importing technetium-99m (Tc-99m) generators from the United States to supply Australian hospitals, clinics and pharmaceutical suppliers. 

Technetium-99m (Tc-99m) Generator production at ANSTO 27/06/2018

Technetium-99m (Tc-99m) is used in hospitals around the world to diagnose a variety of heart, lung and musculoskeletal conditions, as well as cancers. It is the most common nuclear medicine, with global demand estimated to be up to 40 million doses a year, produced by experts with a small network of 11* nuclear reactors worldwide.

Nuclear medicine production at ANSTO 08/06/2018

Media Statement on nuclear medicine production

Nuclear medicine supplies guaranteed during South Sydney fire crisis 17/04/2018

ANSTO to reopen to staff tomorrow 18th, April. School holiday workshops, external tours cancelled until Monday.

ANSTO continues to take advice about bushfires in region 15/04/2018

ANSTO always works with local emergency services, and the Rural Fire Service has advised no risk to ANSTO as a result of the fires in the vicinity of our Lucas Heights campus.


Australia’s OPAL multi-purpose reactor prepares for new milestone 12/04/2018

In mid-2018, ANSTO, together with several State and Federal Government agencies, will undertake Australia’s 10th routine transport of spent nuclear fuel assemblies.

ANSTO recognises local Indigenous heritage in new mural 18/12/2017

ANSTO has recognised the indigenous culture and history that surrounds our campus, with the creation of a Dharawal Mural.

Report to the independent nuclear regulator, ARPANSA, and the IAEA 14/12/2017

Today the independent nuclear regulator, ARPANSA, has released an Inspection Report in relation to ANSTO’s radiopharmaceutical production facilities.

ANM media centre thumbnail
Australia’s new Mo-99 manufacturing facility reaches practical completion 30/11/2017

The ANSTO Nuclear Medicine (ANM) project has achieved a new milestone, reaching practical completion for the Molybdenum-99 (Mo-99) production facility, with contractors handing over the facility to the Australian Nuclear Science and Technology Organisation (ANSTO) to complete the final stages of commissioning.

ANSTO's best and brightest recognised in 2017 research awards 27/11/2017

The man behind Australia’s development and advanced manufacturing of nuclear medicine used in hospitals to diagnose cancers and heart disease has been amongst a number of researchers recognised for their achievements at the ANSTO Awards in Nuclear Science and Technology 2017 presentation dinner.

Find more...

Media enquiry form

If you have a media enquiry please call
Phil McCall: +61 438 619 987


Send »

Please provide us with your name, phone number and
email so we can get back to you.

Error: Enquiry was not sent! Check all fields have been populated correctly.
Success: Enquiry was sent successfully.

Publications »